首页 | 本学科首页   官方微博 | 高级检索  
检索        


Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised,controlled, phase 2b/3 trial
Institution:1. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy;2. HPB Surgery, Hepatology and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy;3. Clinical Epidemiology and Trial Organization, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy;4. General Surgery and Abdominal Transplantation Unit, Hepatology, University of Milano-Bicocca andNiguarda-CàGranda Hospital, Milan, Italy;5. Department of Organ Failure and Transplantation, Gastroenterology, Hepatology and Liver Transplantation, Ospedale Papa Giovanni XXIII, Bergamo, Italy;6. General Surgery 2U and Liver Transplantation Center, University of Turin, AOU Cittàdella Salute e della Scienza di Torino, Turin, Italy;7. General and Liver Transplant Surgery Unit, Foundation IRCCS Ca'' Granda Ospedale Maggiore Policlinico, Milan, Italy;8. Division of Gastroenterology and Hepatology, CRC A M and A Migliavacca Center for Liver Disease, Foundation IRCCS Ca'' Granda Ospedale Maggiore Policlinico, Milan, Italy;9. Hepatobiliary and Abdominal Transplantation Surgery, Hepatology, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy;10. Department of Surgical Sciences and Medical Sciences University of Rome-Tor Vergata, Rome, Italy;11. Department of General Surgery and Organ Transplantation, Sapienza University, Rome, Italy;12. Abdominal Surgery and Organ Transplantation Unit, Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, ISMETT, Palermo, Italy
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号